TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.60$ +2.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

Genelux Corporation (GNLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
-7.2 -7.2 -6.6 -3.6 -20 -21 -25
0.5 0.7 0.9 1.0 1.0 0.9 0.2
5.3 4.3 2.4 5.2 6.1 5.9
3.8 5.3 4.6 2.1
0.1 0.4 4.1 -1.7 -3.3 0.8 -1.0
1.8 0.0 0.0 0.0 1.0 0.4 1.1
-1.8 0.0 0.0 0.0 -15 -8.1 12
1.5 9.2 -0.6 1.0 0.2 0.0
7.9 18 -0.3 -0.5 44 29 9.9
-1.1 11 -6.9 -4.1 9.0 -0.9 -3.2
-9.0 -7.2 -6.6 -3.6 -21 -22 -26

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?